While there is no literature linking the influence of aldehyde dehydrogenases on oxidative phosphorylation in AD, there is evidence of their interdependence from the cancer literature [41], supporting the hypothesis that ALDH3A2 may directly modulate the ETC in AD pathogenesis as well. This evidence concerns the gene ALDH3A2 and Alzheimer disease.